相关实验视频

Updated: Jun 26, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

帕金森病中的BDNF/TrkB激活剂:一种新的治疗策略

Naif H Ali¹, Hayder M Al-Kuraishy², Ali I Al-Gareeb³

¹Department of Internal Medicine, Medical College, Najran University, Najran, Saudi Arabia.

Journal of cellular and molecular medicine

|May 16, 2024

概括

大脑衍生神经营养因子 (BDNF) 和其受体热氨酸受体激酶B型 (TrkB) 信号传递在帕金森病 (PD) 中减少. 激活这种途径可能有助于管理PD神经病理.

科学领域:

神经科学是一个神经科学.
神经退行性疾病神经退行性疾病
分子生物学分子生物学

背景情况:

帕金森病 (PD) 涉及黑体中多巴胺基神经元退化,导致运动和非运动症状.
患PD神经病理的特征是线粒体功能障碍,氧化损伤和亡.
大脑衍生神经营养因子 (BDNF) 和其受体氨酸受体激酶类型B (TrkB) 在神经元的生存和功能中起着至关重要的作用.

研究的目的:

审查BDNF/TrkB通路激活剂在治疗帕金森病中的潜在治疗作用.
探索如何调节BDNF/TrkB信号可以抵消PD相关的神经病理.

主要方法:

文献综述侧重于BDNF和TrkB在PD中的参与.
对研究BDNF/TrkB信号传递对多巴胺能神经元存活率和α-synuclein积累的影响的分析.
检查BDNF/TrkB通路激活对PD进展的影响.

主要成果:

BDNF促进多巴胺基神经元的存活,并增强条状神经元的活动.
TrkB受体缺乏导致多巴胺基神经元退化和α-synuclein积累.
在早期的PD中,BDNF/TrkB信号减少,与疾病的严重程度相关.

结论:

减少BDNF/TrkB信号传递是帕金森病的一个关键特征,与其进展和并发症有关.
准和激活BDNF/TrkB通路是减轻PD神经病理学的有希望的治疗策略.
通过BDNF等生长因子调节线粒体功能障碍,氧化应激和亡,为PD管理提供了一种新的方法.

关键词:

这就是为什么BDNF是BDNF.作为BDNF/TrkB激活剂的帕金森病的疾病.这就是为什么TrkBB.

更多相关视频

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.